Title |
Bicarbonate versus lactate solutions for acute peritoneal dialysis
|
---|---|
Published in |
Cochrane database of systematic reviews, July 2014
|
DOI | 10.1002/14651858.cd007034.pub3 |
Pubmed ID | |
Authors |
Zheng Gang Bai, KeHu Yang, Jin Hui Tian, Bin Ma, Yali Liu, Lei Jiang, Jiying Tan, Tian Xi Liu, Iris Chi |
Abstract |
The high mortality rate among critically ill patients with acute kidney injury (AKI) remains an unsolved problem in intensive care medicine, despite the use of renal replacement therapy (RRT). Increasing evidence from clinical studies in adults and children suggests that the new peritoneal dialysis (PD) fluids may allow for better long-term preservation of peritoneal morphology and function. Formation of glucose degradation products (GDPs) can be reduced and even avoided with the use of newer "biocompatible" solutions. However, it is still unclear if there are any differences in using conventional (lactate) solutions compared with low GDP (bicarbonate) solutions for acute PD. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 1% |
Spain | 1 | <1% |
Slovenia | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 149 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 25 | 16% |
Researcher | 16 | 10% |
Student > Bachelor | 15 | 10% |
Student > Ph. D. Student | 13 | 8% |
Student > Doctoral Student | 11 | 7% |
Other | 30 | 19% |
Unknown | 44 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 63 | 41% |
Nursing and Health Professions | 12 | 8% |
Biochemistry, Genetics and Molecular Biology | 6 | 4% |
Psychology | 4 | 3% |
Engineering | 4 | 3% |
Other | 15 | 10% |
Unknown | 50 | 32% |